Vision Retirement’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Hold
243
– – 0.04% 141
2026
Q2
$152K Hold
243
– – 0.04% 147
2026
Q1
$188K Hold
243
– – 0.05% 126
2025
Q4
$188K Buy
+243
New +$165K 0.05% 128

Other funds holding REGN

Vision Retirement's REGN Position: Q3 2026 in Review

Vision Retirement held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 243 shares worth $184K. The position accounts for 0.04% of the portfolio, ranked #141.

Vision Retirement first reported a position in REGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $188K in Q1 2026. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Vision Retirement held 243 shares of Regeneron Pharmaceuticals worth $184K as of Q3 2026.
  • Vision Retirement left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.04% of Vision Retirement's portfolio in Q3 2026, its #141 holding.
  • Vision Retirement first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Vision Retirement's Regeneron Pharmaceuticals position peaked at $188K in Q1 2026.
  • 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Vision Retirement's 13F filing for Q3 2026, filed 13 Nov 2026.